| The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia (NCT04013555) | University of Maryland, Baltimore | 2020-01-20 |
| Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode (NCT04203056) | University of California, Los Angeles | 2019-12-16 |
| Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life (NCT03757988) | University of North Carolina, Chapel Hill | 2018-12-06 |
| Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 (NCT03201757) | Alkermes, Inc. | 2017-06-15 |
| Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia (NCT03061136) | Palo Alto Veterans Institute for Research | 2016-10-01 |
| Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder (NCT03043820) | Iris Sommer | 2016-08-01 |
| RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) (NCT02160249) | London School of Hygiene and Tropical Medicine | 2015-09-01 |
| Electronic Cigarettes in Smokers With Mental Illness (NCT02212041) | King's College London | 2014-09-24 |
| Prednisolone Addition for Patients With Recent-onset Psychotic Disorder (NCT02949232) | UMC Utrecht | 2014-07-01 |
| Integrated Metacognitive Therapy in First Episode Psychosis (NCT02131116) | Indiana University | 2014-05-01 |
| rTMS in First Episode Psychosis (NCT02131129) | Indiana University | 2014-04-30 |
| Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia (NCT02787122) | Philipps University Marburg | 2014-01-01 |
| Association of Amisulpride Response in Schizophrenia With Brain Image (NCT02095938) | CHA University | 2014-01-01 |
| RCT of Methotrexate Added to Treatment As Usual in Schizophrenia (NCT02074319) | Pakistan Institute of Living and Learning | 2013-12-01 |
| Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode (NCT02267070) | University of California, Los Angeles | 2013-11-01 |
| Simvastatin Addition for Patients With Recent-onset Schizophrenia (NCT01999309) | Iris Sommer | 2013-10-01 |
| Effectiveness of Adherence Therapy for Schizophrenia (NCT01780116) | The Hong Kong Polytechnic University | 2013-05-01 |
| Omega-3 Dietary Supplements in Schizophrenia (NCT01786239) | Delbert Robinson | 2013-05-01 |
| Antipsychotic Effects on Brain Function in Schizophrenia (NCT01913327) | University of California, San Francisco | 2013-04-01 |
| Contrasting Group Therapy Methods for Psychosis (NCT01764568) | University of British Columbia | 2013-01-01 |
| Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents (NCT01731119) | University of North Carolina, Chapel Hill | 2012-12-01 |
| Lifestyle Intervention for Diabetes and Weight Management in Psychosis (NCT01828931) | Centre for Addiction and Mental Health | 2012-12-01 |
| Biomarkers in First Episode Schizophrenia (NCT02033382) | NYU Langone Health | 2012-07-01 |
| Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia (NCT02137993) | HK inno.N Corporation | 2012-03-01 |
| Optimization of Treatment and Management of Schizophrenia in Europe (NCT01248195) | Rene Kahn | 2011-05-01 |
| Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen (NCT01555814) | Birte Glenthoj | 2011-05-01 |
| Brain Circuits in Schizophrenia and Smoking (NCT01425684) | University of Maryland, Baltimore | 2010-12-20 |
| Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States (NCT01425671) | University of Maryland, Baltimore | 2010-11-30 |
| Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis (NCT01216891) | Research Foundation for Mental Hygiene, Inc. | 2010-10-01 |
| Randomized Double Blind Placebo Control Study in Patients with Schizophrenia (NCT01602029) | Pakistan Institute of Living and Learning | 2010-08-01 |
| DECIFER: Depression and Citalopram In First Episode Recovery (NCT01041274) | NYU Langone Health | 2010-01-01 |
| Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia (NCT01029769) | Technical University of Munich | 2009-12-01 |
| Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study (NCT01269710) | University of North Carolina, Chapel Hill | 2009-10-01 |
| Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia. (NCT00716755) | Centre for Addiction and Mental Health | 2009-10-01 |
| Role of Anti-Inflammatory Agents in Patients With Schizophrenia (NCT00929955) | Pakistan Institute of Living and Learning | 2009-06-01 |
| Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia (NCT00847600) | Sha'ar Menashe Mental Health Center | 2009-03-01 |
| Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia (NCT00825045) | Centre for Addiction and Mental Health | 2008-12-01 |
| Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy (NCT00791440) | New York State Psychiatric Institute | 2008-11-01 |
| Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects (NCT00734435) | Orexigen Therapeutics, Inc | 2008-09-01 |
| Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia (NCT00749970) | AstraZeneca | 2008-07-01 |
| Schizophrenic Patients in Integrated Care (NCT00681629) | AstraZeneca | 2008-07-01 |
| Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain (NCT00709202) | Nathan Kline Institute for Psychiatric Research | 2008-07-01 |
| A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia (NCT00686400) | Martin-Luther-Universität Halle-Wittenberg | 2008-05-01 |
| An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders (NCT01855074) | Janssen-Cilag Ltd. | 2007-11-01 |
| Anticholinergic Burden in Schizophrenia (NCT00715377) | Centre for Addiction and Mental Health | 2007-06-01 |
| Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis (NCT00465920) | University of Cologne | 2007-05-01 |
| Donepezil Double Blind Trial for ECT Memory Disfunction (NCT00465283) | BeerYaakov Mental Health Center | 2007-05-01 |
| Varenicline Adjunctive Treatment in Schizophrenia (NCT00492349) | University of Maryland, Baltimore | 2007-05-01 |
| Integrated Care in Psychotic Disorders With Severe Mental Illness (NCT01888627) | Universitätsklinikum Hamburg-Eppendorf | 2007-05-01 |
| Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia (NCT00361543) | The Alfred | 2006-08-01 |
| An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. (NCT00391261) | Cambridge Health Alliance | 2006-07-01 |
| Open-label Ziprasidone Study for Psychosis Treatment in Adolescents (NCT00421954) | New York State Psychiatric Institute | 2006-05-01 |
| Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia (NCT00337662) | Eli Lilly and Company | 2006-05-01 |
| Optimizing Response in Psychosis Study (NCT00314327) | Northwell Health | 2006-04-01 |
| Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine (NCT00312598) | University of North Carolina, Chapel Hill | 2005-08-01 |
| PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders (NCT00399334) | Janssen-Cilag, S.A. | 2005-06-01 |
| Study of Amantadine for Weight Stabilization During Olanzapine Treatment (NCT00287352) | University of North Carolina, Chapel Hill | 2005-05-01 |
| Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia (NCT00434980) | Beth Israel Deaconess Medical Center | 2005-02-01 |
| A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis (NCT00246259) | Janssen-Ortho Inc., Canada | 2004-10-01 |
| The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study (NCT00206557) | The Alfred | 2002-10-01 |
| Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia (NCT00511628) | Janssen-Cilag, S.A. | 2001-07-01 |
| Clinical Trial of Dipyridamole in Schizophrenia (NCT00349973) | University of Maryland, Baltimore | 2001-05-01 |
| Clinical Estradiol Trial in Women With Schizophrenia (NCT00206570) | Bayside Health | 2001-01-01 |